Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
01 2022
Historique:
received: 29 12 2020
revised: 16 08 2021
accepted: 21 09 2021
pubmed: 15 9 2021
medline: 19 1 2022
entrez: 14 9 2021
Statut: ppublish

Résumé

Inactivation of the Apc gene is a critical early event in the development of sporadic colorectal cancer (CRC). Expression of serine-threonine kinase receptor-associated protein (STRAP) is elevated in CRCs and is associated with poor outcomes. We investigated the role of STRAP in Apc mutation-induced intestinal tumor initiation and progression. We generated Strap intestinal epithelial knockout mice (Strap Strap deficiency extended the average survival of Apc STRAP is a target of, and is required in, Apc mutation/deletion-induced intestinal tumorigenesis through a novel feed-forward STRAP/MEK-ERK/Wnt-β-catenin/STRAP regulatory axis.

Sections du résumé

BACKGROUND & AIMS
Inactivation of the Apc gene is a critical early event in the development of sporadic colorectal cancer (CRC). Expression of serine-threonine kinase receptor-associated protein (STRAP) is elevated in CRCs and is associated with poor outcomes. We investigated the role of STRAP in Apc mutation-induced intestinal tumor initiation and progression.
METHODS
We generated Strap intestinal epithelial knockout mice (Strap
RESULTS
Strap deficiency extended the average survival of Apc
CONCLUSIONS
STRAP is a target of, and is required in, Apc mutation/deletion-induced intestinal tumorigenesis through a novel feed-forward STRAP/MEK-ERK/Wnt-β-catenin/STRAP regulatory axis.

Identifiants

pubmed: 34520730
pii: S0016-5085(21)03489-2
doi: 10.1053/j.gastro.2021.09.010
pmc: PMC8678216
mid: NIHMS1740081
pii:
doi:

Substances chimiques

RNA-Binding Proteins 0
STRAP protein, human 0
STRAP protein, mouse 0
Extracellular Signal-Regulated MAP Kinases EC 2.7.11.24
Mitogen-Activated Protein Kinase Kinases EC 2.7.12.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-208

Subventions

Organisme : NCI NIH HHS
ID : U54 CA118638
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA013148
Pays : United States
Organisme : BLRD VA
ID : I01 BX005143
Pays : United States
Organisme : BLRD VA
ID : I01 BX003497
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA095195
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA118623
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA118948
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Références

Genes Dev. 2005 Apr 15;19(8):877-90
pubmed: 15833914
Neoplasia. 2004 Nov-Dec;6(6):813-20
pubmed: 15720808
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Science. 2009 Jul 24;325(5939):433
pubmed: 19628861
J Biol Chem. 1998 Jul 17;273(29):18623-32
pubmed: 9660836
J Biol Chem. 1998 Dec 25;273(52):34671-4
pubmed: 9856985
Oncogene. 2015 Sep 17;34(38):4914-27
pubmed: 25500543
Oncotarget. 2016 Mar 29;7(13):16023-37
pubmed: 26910283
Nat Commun. 2020 Nov 23;11(1):5941
pubmed: 33230114
Genes Dev. 2006 Mar 15;20(6):666-74
pubmed: 16543220
Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5066-E5075
pubmed: 29760071
Nature. 2009 Jan 29;457(7229):608-11
pubmed: 19092804
Front Biosci (Landmark Ed). 2011 Jan 01;16:105-15
pubmed: 21196161
Hum Mol Genet. 2001 Apr;10(7):721-33
pubmed: 11257105
Nature. 2007 Apr 5;446(7136):676-9
pubmed: 17377531
Oncogene. 2007 May 14;26(22):3291-310
pubmed: 17496923
Pathol Int. 2007 Apr;57(4):178-82
pubmed: 17316412
J Biol Chem. 2012 Mar 2;287(10):7026-38
pubmed: 22241478
Nat Genet. 2020 Jun;52(6):594-603
pubmed: 32451460
Cancer Res. 2006 Jun 15;66(12):6156-66
pubmed: 16778189
Nat Rev Drug Discov. 2014 Jul;13(7):513-32
pubmed: 24981364
Cold Spring Harb Perspect Biol. 2009 Aug;1(2):a002881
pubmed: 20066091
Cancer Res. 2017 Oct 15;77(20):5464-5478
pubmed: 28827371
Genome Biol. 2007;8(7):R131
pubmed: 17615082
Cancer Res. 2000 Jan 1;60(1):13-7
pubmed: 10646843
J Vis Exp. 2014 Aug 11;(90):e51765
pubmed: 25146755
Cell. 2015 Jun 18;161(7):1539-1552
pubmed: 26091037
Cancer Res. 2006 Nov 15;66(22):10824-32
pubmed: 17108118
J Biol Chem. 2002 Sep 6;277(36):33275-83
pubmed: 12065599

Auteurs

Trung Vu (T)

Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama; Birmingham Veterans Affairs Medical Center, Birmingham, Alabama.

Arunima Datta (A)

Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama; Birmingham Veterans Affairs Medical Center, Birmingham, Alabama.

Carolyn Banister (C)

Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina.

Lin Jin (L)

Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama; Birmingham Veterans Affairs Medical Center, Birmingham, Alabama.

Guandou Yuan (G)

Division of Hepatobiliary Surgery, Department of Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Temesgen Samuel (T)

Department of Pathobiology, Tuskegee University, Tuskegee, Alabama.

Sejong Bae (S)

Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.

Isam-Eldin Eltoum (IE)

Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.

Upender Manne (U)

Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.

Bixiang Zhang (B)

Department of Surgery, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Robert S Welner (RS)

Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.

Kasturi Mitra (K)

Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.

Phillip Buckhaults (P)

Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina.

Pran K Datta (PK)

Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama; Birmingham Veterans Affairs Medical Center, Birmingham, Alabama. Electronic address: prandatta@uabmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH